Andrea Corcoran
Director of Finance/CFO bei ATEA PHARMACEUTICALS, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Derzeit bekleidet Andrea J. Corcoran die Position des Chief Financial Officer, Secretary & EVP-Legal bei Atea Pharmaceuticals, Inc. In der Vergangenheit war Andrea J. Corcoran als Associate bei Kelley Drye & Warren LLP, als Senior Vice President-Finance & Strategy bei iBio, Inc., als Secretary & General Counsel von Tolerx, Inc., als Associate bei Edwards & Angell LLP und als General Counsel & Executive Vice President bei Idenix Pharmaceuticals LLC tätig. Andrea J. Corcoran erhielt einen Undergraduate-Abschluss vom Providence College und einen Graduate-Abschluss vom Boston College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.02.2024 | 670 208 ( 0,80% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Andrea Corcoran
Unternehmen | Position | Beginn |
---|---|---|
ATEA PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.10.2020 |
Ehemalige bekannte Positionen von Andrea Corcoran
Unternehmen | Position | Ende |
---|---|---|
IBIO, INC. | Corporate Officer/Principal | 01.01.2012 |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | General Counsel | 01.01.2011 |
IDENIX PHARMACEUTICALS INC | General Counsel | 01.01.2007 |
Edwards & Angell LLP
Edwards & Angell LLP Miscellaneous Commercial ServicesCommercial Services Edwards & Angell provides legal services to clients primarily to clients in three sectors; financial services, private equity and venture capital and technology. The firm's practices include bankruptcy and creditor's rights, insurance, reinsurance, labor law, employment law, litigation, patents and intellectual property, real estate, media, trust and estate. It was founded in the year 1894. | Corporate Officer/Principal | - |
Kelley Drye & Warren LLP
Kelley Drye & Warren LLP Miscellaneous Commercial ServicesCommercial Services Kelley Drye & Warren LLP provides legal services. Its services include bankruptcy, tax law, and commercial litigation for such blue-chip clients as Dow Chemical, Wells Fargo, and Lucent. The company was founded in 1936 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Andrea Corcoran
Providence College | Undergraduate Degree |
Boston College Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ATEA PHARMACEUTICALS, INC. | Health Technology |
IBIO, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
Edwards & Angell LLP
Edwards & Angell LLP Miscellaneous Commercial ServicesCommercial Services Edwards & Angell provides legal services to clients primarily to clients in three sectors; financial services, private equity and venture capital and technology. The firm's practices include bankruptcy and creditor's rights, insurance, reinsurance, labor law, employment law, litigation, patents and intellectual property, real estate, media, trust and estate. It was founded in the year 1894. | Commercial Services |
Kelley Drye & Warren LLP
Kelley Drye & Warren LLP Miscellaneous Commercial ServicesCommercial Services Kelley Drye & Warren LLP provides legal services. Its services include bankruptcy, tax law, and commercial litigation for such blue-chip clients as Dow Chemical, Wells Fargo, and Lucent. The company was founded in 1936 and is headquartered in New York, NY. | Commercial Services |